Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghulam Mufti

Showing results (21-30 of 64) with videos related to

Pageof 7
Sort By:
Critical Reviews in Oncology/Hematology|July 11, 2013
Epigenetics in focus: pathogenesis of myelodysplastic syndromes and the role of hypomethylating agentsValeria Santini, Ari Melnick, Jaroslaw P Maciejewski, et al.
Leukemia Research|September 17, 2011
Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDSPeter Valent, Barbara J Bain, John M Bennett, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Should patients with high-risk or transformed myelodysplastic syndrome proceed directly to allogeneic transplant without prior cytoreduction by remission-induction chemotherapy or hypomethylating agent therapy?Theo M de Witte, David Bowen, Marie Robin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 9, 2004
IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AMLLucas Chan, Nicola Hardwick, Dave Darling, et al.
Cancer Immunity|July 25, 2013
An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptideNicola Hardwick, Sarah Buchan, Wendy Ingram, et al.
Internal Medicine Journal|April 7, 2018
Anti-type M phospholipase A2 receptor antibody-positive membranous nephropathy as a part of multi-system autoimmune syndrome post-allogeneic stem cell transplantationAditya Tedjaseputra, Donal McLornan, Jill McCormick, et al.
Journal of Virology|September 29, 2005
Conjugation of lentivirus to paramagnetic particles via nonviral proteins allows efficient concentration and infection of primary acute myeloid leukemia cellsLucas Chan, Darren Nesbeth, Taylor Mackey, et al.
British Journal of Haematology|February 18, 2003
A pilot study of antithymocyte globulin (ATG) in the treatment of patients with 'low-risk' myelodysplasiaSally B Killick, Ghulam Mufti, Jamie D Cavenagh, et al.
Blood Cancer Journal|July 13, 2021
Mixed T cell lineage chimerism in acute leukemia/MDS using pre-emptive donor lymphocyte infusion strategy-Is it prognostic?-a single-center retrospective studyVipul Sheth, Victoria Potter, Hugues de Lavallade, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 10, 2020
Early and late-onset veno-occlusive disease/sinusoidal syndrome post allogeneic stem cell transplantation - a real-world UK experienceVarun Mehra, Simon Tetlow, Adrian Choy, et al.
Pageof 7

Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Critical Reviews in Oncology/Hematology|July 11, 2013
Epigenetics in focus: pathogenesis of myelodysplastic syndromes and the role of hypomethylating agentsValeria Santini, Ari Melnick, Jaroslaw P Maciejewski, et al.
Leukemia Research|September 17, 2011
Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDSPeter Valent, Barbara J Bain, John M Bennett, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Should patients with high-risk or transformed myelodysplastic syndrome proceed directly to allogeneic transplant without prior cytoreduction by remission-induction chemotherapy or hypomethylating agent therapy?Theo M de Witte, David Bowen, Marie Robin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 9, 2004
IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AMLLucas Chan, Nicola Hardwick, Dave Darling, et al.
Cancer Immunity|July 25, 2013
An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptideNicola Hardwick, Sarah Buchan, Wendy Ingram, et al.
Internal Medicine Journal|April 7, 2018
Anti-type M phospholipase A2 receptor antibody-positive membranous nephropathy as a part of multi-system autoimmune syndrome post-allogeneic stem cell transplantationAditya Tedjaseputra, Donal McLornan, Jill McCormick, et al.
Journal of Virology|September 29, 2005
Conjugation of lentivirus to paramagnetic particles via nonviral proteins allows efficient concentration and infection of primary acute myeloid leukemia cellsLucas Chan, Darren Nesbeth, Taylor Mackey, et al.
British Journal of Haematology|February 18, 2003
A pilot study of antithymocyte globulin (ATG) in the treatment of patients with 'low-risk' myelodysplasiaSally B Killick, Ghulam Mufti, Jamie D Cavenagh, et al.
Blood Cancer Journal|July 13, 2021
Mixed T cell lineage chimerism in acute leukemia/MDS using pre-emptive donor lymphocyte infusion strategy-Is it prognostic?-a single-center retrospective studyVipul Sheth, Victoria Potter, Hugues de Lavallade, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 10, 2020
Early and late-onset veno-occlusive disease/sinusoidal syndrome post allogeneic stem cell transplantation - a real-world UK experienceVarun Mehra, Simon Tetlow, Adrian Choy, et al.
Pageof 7